<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01936259</url>
  </required_header>
  <id_info>
    <org_study_id>ORTHO.CA.GE1.12</org_study_id>
    <secondary_id>G110207</secondary_id>
    <nct_id>NCT01936259</nct_id>
  </id_info>
  <brief_title>Comprehensive Shoulder System Nano IDE</brief_title>
  <acronym>Nano</acronym>
  <official_title>A Study of the Comprehensive Shoulder System With Nano Humeral Component in Total Shoulder Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical study is to determine the safety and efficacy of the
      Comprehensive® Shoulder System with Nano Humeral Component in Total Shoulder Arthroplasty
      (TSA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this clinical investigation is to establish the safety and efficacy of the
      Comprehensive® Shoulder System with Nano Humeral Component in Total Shoulder Arthroplasty.
      Safety and efficacy of the device will be measured by collection and analysis of the
      following data at the two-year or greater time point (22 months post-operative or longer):

        1. American Shoulder and Elbow Surgeons (ASES) Score

        2. Single Assessment Numeric Evaluation (SANE)

        3. Constant Score

        4. Radiographic assessment of osteolysis, radiolucencies, migration, and subsidence

        5. Comparison of overall adverse event rates including rates of removal/revision and other
           serious adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2013</start_date>
  <completion_date type="Actual">September 27, 2019</completion_date>
  <primary_completion_date type="Actual">November 21, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>American Shoulder and Elbow Surgeon's Score (ASES)</measure>
    <time_frame>22+ Months</time_frame>
    <description>The American Shoulder and Elbow Surgeon's (ASES) Score is a tool used to measure shoulder function. The ASES score is on a scale of 0 to 100, with 0 being the worst possible score and 100 the best. The score consists of two components - pain and activities of daily living.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Shoulders With Absence of Revision/Removal/UADE/Fracture/Dislocation</measure>
    <time_frame>2 years</time_frame>
    <description>This outcome measure calculates the proportion of subjects meeting a success criteria defined in the protocol as &quot;No unanticipated device-related adverse event, and no fracture, perforation of the bone or joint dislocation, and no fracture, perforation or dissociation of the device, and no revision or removal of any component.&quot; All subject records were evaluated for each of the disqualifying factors, and all subjects that failed at least one of the endpoint measures were identified. The success rate is defined as the number of subjects at two years not meeting any of the disqualifying factors compared to the total number of cases present at two years plus all subjects considered failures without two year data.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Shoulders With Radiographic Success</measure>
    <time_frame>2 years</time_frame>
    <description>This outcome measure calculates the proportion of subjects meeting a success criteria defined in the protocol as &quot;Subsidence of the humeral component &lt;5 mm, and migration of the humeral component &lt;5 mm, and no progressive lucency around the humeral component &gt;2 mm in two or more contiguous zones, and migration of the glenoid component &lt;5 mm, and no progressive lucency &gt;2 mm around the entire glenoid component.&quot; All subject records were evaluated by an Independent Radiographic Reviewer (IRR) at each time point for radiographic success based on these criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>American Shoulder and Elbow Surgeon's Score (ASES)</measure>
    <time_frame>Pre-operative, 6 Weeks, 3 Months, 1 Year, 2 Years, 3 Years, 4 Years</time_frame>
    <description>The American Shoulder and Elbow Surgeon's (ASES) Score is a tool used to measure shoulder function. The ASES score is on a scale of 0 to 100, with 0 being the worst possible score and 100 the best. The score consists of two components - pain and activities of daily living.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Single Assessment Numeric Evaluation (SANE) Score</measure>
    <time_frame>6 Weeks, 3 Months, 1 Year, 2 Years, 3 Years, 4 Years</time_frame>
    <description>The Single Assessment Numeric Evaluation (SANE) Score is a tool used to assess the subject's perception of their affected joint. Participants are requested to rate their shoulder function on a scale of 0 to 100, with 0 as the worst option and 100 being normal shoulder function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constant Score Adjusted for Age and Gender</measure>
    <time_frame>Pre-operative, 3 Months, 1 Year, 2 Years, 3 Years, 4 Years</time_frame>
    <description>The Constant-Murley Shoulder Score is a scoring method used by clinicians to assess function of the shoulder. The standard score is on a scale of 0 to 100, with 0 being no shoulder function and 100 being excellent function. The age- and gender-adjusted Constant score normalizes the raw Constant score based on the subject's age and gender. The worst score on the adjusted scale is still 0, but the greatest scores can exceed 100 based on the calculations used for normalization. The scale used in this study was described by Katolik et al.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Shoulders Passing Radiographic Assessment of Radiolucencies and Subsidence</measure>
    <time_frame>2+ years</time_frame>
    <description>All radiographs collected at all follow-up time points were analyzed by the Independent Radiographic reviewer. Subjects were assessed for the presence of radiolucencies considered to be failures of the radiographic co-primary endpoint (No progressive lucency around the humeral component &gt;2 mm in two or more contiguous zones OR no progressive lucency &gt;2 mm around the entire glenoid component) and for the presence of component subsidence. Subjects with the absence of failing radiolucencies and subsidence were considered successes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">258</enrollment>
  <condition>Joint Disease</condition>
  <arm_group>
    <arm_group_label>Comprehensive Mini Humeral Stem</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Comprehensive® Shoulder System with mini stem component, which will be the control device for this clinical investigation and was 510(k) cleared under K060692 on May 30, 2006.
The humeral stem component is manufactured from Ti6Al4V alloy. The taper has a machine finish and accepts the taper adaptor of the humeral head component. The proximal region of the bone-contacting outer surface features a porous coating of plasma-sprayed titanium alloy, while the distal portion is polished. Seventeen stem diameters are available - 4 mm to 20 mm, in 1-mm increments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comprehensive Nano Humeral Component</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The stemless humeral component is manufactured from Ti6Al4V alloy. It consists of a central tapered region and six outer wings. The taper has a machine finish and accepts the taper adaptor of the humeral head component. A small groove is included just below the taper to accept an inserter/impactor. The bone-contacting outer surface features a porous coating of plasma-sprayed titanium alloy for cementless fixation in the proximal humerus. Six sizes are available - 30 mm, 32 mm, 34 mm, 36 mm, 38 mm, and 40 mm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mini Stem</intervention_name>
    <description>The humeral stem component is manufactured from Ti6Al4V alloy. The taper has a machine finish and accepts the taper adaptor of the humeral head component. The proximal region of the bone-contacting outer surface features a porous coating of plasma-sprayed titanium alloy, while the distal portion is polished. Seventeen stem diameters are available - 4 mm to 20 mm, in 1-mm increments.</description>
    <arm_group_label>Comprehensive Mini Humeral Stem</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nano</intervention_name>
    <description>The stemless humeral component is manufactured from Ti6Al4V alloy. It consists of a central tapered region and six outer wings. The taper has a machine finish and accepts the taper adaptor of the humeral head component. A small groove is included just below the taper to accept an inserter/impactor. The bone-contacting outer surface features a porous coating of plasma-sprayed titanium alloy for cementless fixation in the proximal humerus. Six sizes are available - 30 mm, 32 mm, 34 mm, 36 mm, 38 mm, and 40 mm.</description>
    <arm_group_label>Comprehensive Nano Humeral Component</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients for whom the surgeon has confirmed intraoperatively, has no cyst &gt; 1cm and
             not more than one cyst at the implantation site

          -  Patients with non-inflammatory degenerative joint disease including osteoarthritis.

          -  Patients where the device will be used in the correction of a functional deformity
             (deformities preventing congruent articulation of the glenohumeral joint)

          -  Patients with pain and/or loss of function in the shoulder for whom other treatment
             modalities have been unsuccessful.

          -  Patients requiring unilateral or staged bilateral shoulder arthroplasty

          -  Patient must be anatomically and structurally suited to receive the implants (humeral
             neck must be of sufficient diameter to implant at least the smallest nano humeral
             component and the humeral neck is intact).

          -  Patients who are 21-90 years of age at the time of surgery and have reached skeletal
             maturity.

          -  Patients with an ASES score ≤ 40.

        Exclusion Criteria:

          -  Patients diagnosed with avascular necrosis or post-traumatic arthritis of the humeral
             head

          -  Patients found at the time of intraoperative examination to have a single cyst &gt;1 cm
             in size or multiple cysts at the implantation site

          -  Patient presents with shoulder joint infection, sepsis, osteomyelitis or distant foci
             of infections which may spread to the implant site.

          -  Patients with cuff tear arthropathy.

          -  Patients who have undergone a Hemi-, Total, or Reverse Total Shoulder arthroplasty in
             the affected shoulder.

          -  Patient presents with a malunion or non-union of the tuberosities of the proximal
             humerus.

          -  Patients with osteoporosis, osteomalacia, rheumatoid arthritis, metabolic disorders of
             bone, muscle or connective tissue, gross deformity or any other condition of the
             proximal humerus (defined as severe destruction or deformity of the proximal humerus
             that precludes placement of the device) that in the Investigator's medical judgment
             could compromise implant fixation or bone healing.

          -  Rapid bone destruction, marked bone loss or bone resorption apparent on roentgenogram.

          -  Patients with neurologic or other disorders that would either affect the stability of
             the shoulder prosthesis, i.e., Charcot's joint, uncontrolled seizures, etc., or would
             affect their capability or willingness to return to the clinic for assessments and/or
             follow directions.

          -  Bone cancer, either primary or secondary, that affects the shoulder.

          -  Patients presenting with symptoms of chronic steroid use. (oral steroids for a chronic
             condition for 12 months prior to and including the date of surgery)

          -  Patients with a life expectancy of less than three years.

          -  Patients diagnosed with severe shoulder instability

          -  Patients diagnosed with subscapularis incompetence

          -  Patients diagnosed with any condition that may limit their ability to complete the
             consent form or would affect their capability or willingness to return to the clinic
             for assessments and/or follow directions (i.e. mental illness)

          -  Patients with known metal allergy

          -  Patients who refuse to sign the Institutional Review Board (IRB) approved consent form

          -  Patients who are found intraoperatively to require a specific treatment and are unable
             to be randomized.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Arizona Institute for Sports, Knees, and Shoulders</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85255</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holy Cross Hospital</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ortho NorthEast</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedic Clinic</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Towson Orthopaedic Associates</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Joint Implant Surgeons</name>
      <address>
        <city>New Albany</city>
        <state>Ohio</state>
        <zip>43054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Campbell Clinic Orthopaedics</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Francis Medical Center</name>
      <address>
        <city>Midlothian</city>
        <state>Virginia</state>
        <zip>23114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>August 23, 2013</study_first_submitted>
  <study_first_submitted_qc>September 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2013</study_first_posted>
  <results_first_submitted>November 5, 2019</results_first_submitted>
  <results_first_submitted_qc>January 7, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">January 13, 2020</results_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Shoulder</keyword>
  <keyword>Joint</keyword>
  <keyword>Osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/59/NCT01936259/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Due to competitive enrollment, one extra shoulder was randomized and enrolled into the study in the Control group as the site was not aware the study had reached full enrollment.
258 individual subjects were enrolled in the study. 7 subjects underwent study procedures bilaterally, resulting in 265 shoulders enrolled in the study.</recruitment_details>
      <pre_assignment_details>Subjects were randomized 1:1 to either the Comprehensive Shoulder System with Nano Humeral Component (Investigational) or the Comprehensive Shoulder System with Mini Humeral Stem (Control). Treatment assignments occurred intraoperatively and subjects remained blinded until completion of two-year follow-up for all subjects.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Comprehensive Mini Humeral Stem</title>
          <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
        </group>
        <group group_id="P2">
          <title>Comprehensive Nano Humeral Component</title>
          <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="130"/>
                <participants group_id="P2" count="131"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="118"/>
                <participants group_id="P2" count="111"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>258 individual subjects were enrolled in the study. 7 subjects underwent study procedures bilaterally, resulting in 265 shoulders enrolled in the study. Of the 7 bilateral subjects, 1 received two investigational devices, 3 received two control devices, and 3 received one of each device.</population>
      <group_list>
        <group group_id="B1">
          <title>Comprehensive Mini Humeral Stem</title>
          <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
        </group>
        <group group_id="B2">
          <title>Comprehensive Nano Humeral Component</title>
          <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="130"/>
            <count group_id="B2" value="131"/>
            <count group_id="B3" value="258"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>Shoulders</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="133"/>
            <count group_id="B2" value="132"/>
            <count group_id="B3" value="265"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Shoulders</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.1" spread="9.6"/>
                    <measurement group_id="B2" value="63.1" spread="9.0"/>
                    <measurement group_id="B3" value="62.6" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Shoulders</units>
          <param>Count of Units</param>
          <units_analyzed>Shoulders</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="89"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Shoulders</units>
          <param>Count of Units</param>
          <units_analyzed>Shoulders</units_analyzed>
          <class_list>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="126"/>
                    <measurement group_id="B3" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Shoulders</units>
          <param>Number</param>
          <units_analyzed>Shoulders</units_analyzed>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="133"/>
                    <measurement group_id="B2" value="132"/>
                    <measurement group_id="B3" value="265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Procedure on Unilateral/Bilateral Patient</title>
          <description>Seven subjects underwent a study procedure on each shoulder, and are classified as bilateral subjects. This measure defines how many study devices were implanted in bilateral subjects and unilateral subjects.</description>
          <units>Shoulders</units>
          <param>Count of Units</param>
          <units_analyzed>Shoulders</units_analyzed>
          <class_list>
            <class>
              <title>Bilateral</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unilateral</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="127"/>
                    <measurement group_id="B3" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>American Shoulder and Elbow Surgeon's Score (ASES)</title>
        <description>The American Shoulder and Elbow Surgeon's (ASES) Score is a tool used to measure shoulder function. The ASES score is on a scale of 0 to 100, with 0 being the worst possible score and 100 the best. The score consists of two components - pain and activities of daily living.</description>
        <time_frame>22+ Months</time_frame>
        <population>All subjects with ASES data available at the two year visit were assessed.</population>
        <group_list>
          <group group_id="O1">
            <title>Comprehensive Mini Humeral Stem</title>
            <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
          </group>
          <group group_id="O2">
            <title>Comprehensive Nano Humeral Component</title>
            <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
          </group>
        </group_list>
        <measure>
          <title>American Shoulder and Elbow Surgeon's Score (ASES)</title>
          <description>The American Shoulder and Elbow Surgeon's (ASES) Score is a tool used to measure shoulder function. The ASES score is on a scale of 0 to 100, with 0 being the worst possible score and 100 the best. The score consists of two components - pain and activities of daily living.</description>
          <population>All subjects with ASES data available at the two year visit were assessed.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Shoulders</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="111"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Shoulders</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="121"/>
                <count group_id="O2" value="112"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.20" spread="13.51"/>
                    <measurement group_id="O2" value="92.47" spread="14.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Shoulders With Absence of Revision/Removal/UADE/Fracture/Dislocation</title>
        <description>This outcome measure calculates the proportion of subjects meeting a success criteria defined in the protocol as &quot;No unanticipated device-related adverse event, and no fracture, perforation of the bone or joint dislocation, and no fracture, perforation or dissociation of the device, and no revision or removal of any component.&quot; All subject records were evaluated for each of the disqualifying factors, and all subjects that failed at least one of the endpoint measures were identified. The success rate is defined as the number of subjects at two years not meeting any of the disqualifying factors compared to the total number of cases present at two years plus all subjects considered failures without two year data.</description>
        <time_frame>2 years</time_frame>
        <population>The total number of cases for each group includes all subjects with two year data, plus all subjects considered failures without two year data.</population>
        <group_list>
          <group group_id="O1">
            <title>Comprehensive Mini Humeral Stem</title>
            <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
          </group>
          <group group_id="O2">
            <title>Comprehensive Nano Humeral Component</title>
            <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Shoulders With Absence of Revision/Removal/UADE/Fracture/Dislocation</title>
          <description>This outcome measure calculates the proportion of subjects meeting a success criteria defined in the protocol as &quot;No unanticipated device-related adverse event, and no fracture, perforation of the bone or joint dislocation, and no fracture, perforation or dissociation of the device, and no revision or removal of any component.&quot; All subject records were evaluated for each of the disqualifying factors, and all subjects that failed at least one of the endpoint measures were identified. The success rate is defined as the number of subjects at two years not meeting any of the disqualifying factors compared to the total number of cases present at two years plus all subjects considered failures without two year data.</description>
          <population>The total number of cases for each group includes all subjects with two year data, plus all subjects considered failures without two year data.</population>
          <units>Shoulders</units>
          <param>Count of Units</param>
          <units_analyzed>Shoulders</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="115"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Shoulders</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="116"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Success Shoulders</title>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="107"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Failure Shoulders</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Shoulders With Radiographic Success</title>
        <description>This outcome measure calculates the proportion of subjects meeting a success criteria defined in the protocol as &quot;Subsidence of the humeral component &lt;5 mm, and migration of the humeral component &lt;5 mm, and no progressive lucency around the humeral component &gt;2 mm in two or more contiguous zones, and migration of the glenoid component &lt;5 mm, and no progressive lucency &gt;2 mm around the entire glenoid component.&quot; All subject records were evaluated by an Independent Radiographic Reviewer (IRR) at each time point for radiographic success based on these criteria.</description>
        <time_frame>2 years</time_frame>
        <population>All subjects at each time point were evaluated for radiographic success based on these criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Comprehensive Mini Humeral Stem</title>
            <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
          </group>
          <group group_id="O2">
            <title>Comprehensive Nano Humeral Component</title>
            <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Shoulders With Radiographic Success</title>
          <description>This outcome measure calculates the proportion of subjects meeting a success criteria defined in the protocol as &quot;Subsidence of the humeral component &lt;5 mm, and migration of the humeral component &lt;5 mm, and no progressive lucency around the humeral component &gt;2 mm in two or more contiguous zones, and migration of the glenoid component &lt;5 mm, and no progressive lucency &gt;2 mm around the entire glenoid component.&quot; All subject records were evaluated by an Independent Radiographic Reviewer (IRR) at each time point for radiographic success based on these criteria.</description>
          <population>All subjects at each time point were evaluated for radiographic success based on these criteria.</population>
          <units>Shoulders</units>
          <param>Count of Units</param>
          <units_analyzed>Shoulders</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Shoulders</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Success Shoulders</title>
                  <measurement_list>
                    <measurement group_id="O1" value="133"/>
                    <measurement group_id="O2" value="132"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Failure Shoulders</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>American Shoulder and Elbow Surgeon's Score (ASES)</title>
        <description>The American Shoulder and Elbow Surgeon's (ASES) Score is a tool used to measure shoulder function. The ASES score is on a scale of 0 to 100, with 0 being the worst possible score and 100 the best. The score consists of two components - pain and activities of daily living.</description>
        <time_frame>Pre-operative, 6 Weeks, 3 Months, 1 Year, 2 Years, 3 Years, 4 Years</time_frame>
        <population>All subjects with an ASES score collected at each specified study time period were assessed.</population>
        <group_list>
          <group group_id="O1">
            <title>Comprehensive Mini Humeral Stem</title>
            <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
          </group>
          <group group_id="O2">
            <title>Comprehensive Nano Humeral Component</title>
            <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
          </group>
        </group_list>
        <measure>
          <title>American Shoulder and Elbow Surgeon's Score (ASES)</title>
          <description>The American Shoulder and Elbow Surgeon's (ASES) Score is a tool used to measure shoulder function. The ASES score is on a scale of 0 to 100, with 0 being the worst possible score and 100 the best. The score consists of two components - pain and activities of daily living.</description>
          <population>All subjects with an ASES score collected at each specified study time period were assessed.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Shoulders</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Shoulders</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-operative</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="130"/>
                    <count group_id="O2" value="131"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="133"/>
                    <count group_id="O2" value="132"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.8" spread="9.6"/>
                    <measurement group_id="O2" value="25.1" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="127"/>
                    <count group_id="O2" value="131"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="130"/>
                    <count group_id="O2" value="132"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.1" spread="18.3"/>
                    <measurement group_id="O2" value="61.5" spread="17.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="129"/>
                    <count group_id="O2" value="129"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="132"/>
                    <count group_id="O2" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.2" spread="16.4"/>
                    <measurement group_id="O2" value="80.5" spread="15.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="120"/>
                    <count group_id="O2" value="124"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="125"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.2" spread="12.8"/>
                    <measurement group_id="O2" value="92.8" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="118"/>
                    <count group_id="O2" value="111"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="112"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.2" spread="13.5"/>
                    <measurement group_id="O2" value="92.5" spread="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="68"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="69"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.0" spread="9.8"/>
                    <measurement group_id="O2" value="90.0" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.1" spread="6.4"/>
                    <measurement group_id="O2" value="94.3" spread="11.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Single Assessment Numeric Evaluation (SANE) Score</title>
        <description>The Single Assessment Numeric Evaluation (SANE) Score is a tool used to assess the subject's perception of their affected joint. Participants are requested to rate their shoulder function on a scale of 0 to 100, with 0 as the worst option and 100 being normal shoulder function.</description>
        <time_frame>6 Weeks, 3 Months, 1 Year, 2 Years, 3 Years, 4 Years</time_frame>
        <population>All subjects with a SANE score collected at each specified study time period were assessed.</population>
        <group_list>
          <group group_id="O1">
            <title>Comprehensive Mini Humeral Stem</title>
            <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
          </group>
          <group group_id="O2">
            <title>Comprehensive Nano Humeral Component</title>
            <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
          </group>
        </group_list>
        <measure>
          <title>Single Assessment Numeric Evaluation (SANE) Score</title>
          <description>The Single Assessment Numeric Evaluation (SANE) Score is a tool used to assess the subject's perception of their affected joint. Participants are requested to rate their shoulder function on a scale of 0 to 100, with 0 as the worst option and 100 being normal shoulder function.</description>
          <population>All subjects with a SANE score collected at each specified study time period were assessed.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Shoulders</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Shoulders</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6 Weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="127"/>
                    <count group_id="O2" value="130"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="130"/>
                    <count group_id="O2" value="131"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.7" spread="24.2"/>
                    <measurement group_id="O2" value="53.7" spread="23.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="129"/>
                    <count group_id="O2" value="129"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="132"/>
                    <count group_id="O2" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.4" spread="14.9"/>
                    <measurement group_id="O2" value="80.7" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="120"/>
                    <count group_id="O2" value="124"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="125"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.4" spread="12.2"/>
                    <measurement group_id="O2" value="92.2" spread="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="117"/>
                    <count group_id="O2" value="111"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="120"/>
                    <count group_id="O2" value="112"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" spread="11.9"/>
                    <measurement group_id="O2" value="92.3" spread="14.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="67"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.7" spread="6.9"/>
                    <measurement group_id="O2" value="91.5" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="29"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="24"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.4" spread="7.0"/>
                    <measurement group_id="O2" value="93.0" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Constant Score Adjusted for Age and Gender</title>
        <description>The Constant-Murley Shoulder Score is a scoring method used by clinicians to assess function of the shoulder. The standard score is on a scale of 0 to 100, with 0 being no shoulder function and 100 being excellent function. The age- and gender-adjusted Constant score normalizes the raw Constant score based on the subject's age and gender. The worst score on the adjusted scale is still 0, but the greatest scores can exceed 100 based on the calculations used for normalization. The scale used in this study was described by Katolik et al.</description>
        <time_frame>Pre-operative, 3 Months, 1 Year, 2 Years, 3 Years, 4 Years</time_frame>
        <population>All subjects with a Constant score collected at each specified study time period were assessed. The score was not collected at 6 weeks to protect the subscapularis repair.</population>
        <group_list>
          <group group_id="O1">
            <title>Comprehensive Mini Humeral Stem</title>
            <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
          </group>
          <group group_id="O2">
            <title>Comprehensive Nano Humeral Component</title>
            <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
          </group>
        </group_list>
        <measure>
          <title>Constant Score Adjusted for Age and Gender</title>
          <description>The Constant-Murley Shoulder Score is a scoring method used by clinicians to assess function of the shoulder. The standard score is on a scale of 0 to 100, with 0 being no shoulder function and 100 being excellent function. The age- and gender-adjusted Constant score normalizes the raw Constant score based on the subject's age and gender. The worst score on the adjusted scale is still 0, but the greatest scores can exceed 100 based on the calculations used for normalization. The scale used in this study was described by Katolik et al.</description>
          <population>All subjects with a Constant score collected at each specified study time period were assessed. The score was not collected at 6 weeks to protect the subscapularis repair.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Shoulders</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Shoulders</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-operative</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="130"/>
                    <count group_id="O2" value="131"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="133"/>
                    <count group_id="O2" value="132"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.2" spread="17.1"/>
                    <measurement group_id="O2" value="46.3" spread="17.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="127"/>
                    <count group_id="O2" value="129"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="130"/>
                    <count group_id="O2" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.6" spread="18.8"/>
                    <measurement group_id="O2" value="83.1" spread="19.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 Year</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="118"/>
                    <count group_id="O2" value="123"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="124"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.9" spread="16.8"/>
                    <measurement group_id="O2" value="99.8" spread="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="115"/>
                    <count group_id="O2" value="109"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="118"/>
                    <count group_id="O2" value="110"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.2" spread="15.0"/>
                    <measurement group_id="O2" value="101.5" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="72"/>
                    <count group_id="O2" value="65"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="72"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.2" spread="14.4"/>
                    <measurement group_id="O2" value="99.2" spread="17.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 Years</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="28"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>Shoulders</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="22"/>
                    <count group_id="O2" value="28"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.0" spread="12.0"/>
                    <measurement group_id="O2" value="103.5" spread="15.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Shoulders Passing Radiographic Assessment of Radiolucencies and Subsidence</title>
        <description>All radiographs collected at all follow-up time points were analyzed by the Independent Radiographic reviewer. Subjects were assessed for the presence of radiolucencies considered to be failures of the radiographic co-primary endpoint (No progressive lucency around the humeral component &gt;2 mm in two or more contiguous zones OR no progressive lucency &gt;2 mm around the entire glenoid component) and for the presence of component subsidence. Subjects with the absence of failing radiolucencies and subsidence were considered successes.</description>
        <time_frame>2+ years</time_frame>
        <population>All subject radiographs at all time points that were submitted to the Independent Radiographic Reviewer were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Comprehensive Mini Humeral Stem</title>
            <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
          </group>
          <group group_id="O2">
            <title>Comprehensive Nano Humeral Component</title>
            <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Shoulders Passing Radiographic Assessment of Radiolucencies and Subsidence</title>
          <description>All radiographs collected at all follow-up time points were analyzed by the Independent Radiographic reviewer. Subjects were assessed for the presence of radiolucencies considered to be failures of the radiographic co-primary endpoint (No progressive lucency around the humeral component &gt;2 mm in two or more contiguous zones OR no progressive lucency &gt;2 mm around the entire glenoid component) and for the presence of component subsidence. Subjects with the absence of failing radiolucencies and subsidence were considered successes.</description>
          <population>All subject radiographs at all time points that were submitted to the Independent Radiographic Reviewer were analyzed.</population>
          <units>Shoulders</units>
          <param>Count of Units</param>
          <units_analyzed>Shoulders</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Shoulders</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="133"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Success Shoulders</title>
                  <measurement_list>
                    <measurement group_id="O1" value="133"/>
                    <measurement group_id="O2" value="132"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Failure Shoulders</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All adverse events reported throughout each subject's length of participation in the study are included. Length of participation is defined as the implantation date through the earlier of the date of study closure or the date of subject withdrawal, an average of 3.50 years.</time_frame>
      <desc>Subjects are counted only once in each category, even if they experienced more than one adverse event in the specified category.</desc>
      <group_list>
        <group group_id="E1">
          <title>Comprehensive Mini Humeral Stem</title>
          <description>This arm will consist of all subjects implanted with the Control Device (Comprehensive Mini Humeral Stem).</description>
        </group>
        <group group_id="E2">
          <title>Comprehensive Nano Humeral Component</title>
          <description>This arm will consist of all subjects implanted with the Investigational Device (Comprehensive Nano Humeral Component).</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="130"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death (Non-Shoulder Related)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Other General (Non-Shoulder Related) Complication</sub_title>
                <counts group_id="E1" events="62" subjects_affected="44" subjects_at_risk="130"/>
                <counts group_id="E2" events="49" subjects_affected="35" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dislocation / Subluxation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Other Shoulder-Related Complication</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="130"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Implant or Part Failure or Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="118" subjects_at_risk="130"/>
                <counts group_id="E2" subjects_affected="105" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Arrhythmia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other General (Non-Shoulder Related) Complication</sub_title>
                <counts group_id="E1" events="193" subjects_affected="88" subjects_at_risk="130"/>
                <counts group_id="E2" events="130" subjects_affected="72" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Dislocation / Subluxation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Inadequate Range of Motion</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="130"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Unusual Shoulder Pain</sub_title>
                <counts group_id="E1" events="35" subjects_affected="29" subjects_at_risk="130"/>
                <counts group_id="E2" events="23" subjects_affected="18" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Other Shoulder-Related Complication</sub_title>
                <counts group_id="E1" events="95" subjects_affected="58" subjects_at_risk="130"/>
                <counts group_id="E2" events="88" subjects_affected="52" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Nerve Injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Nerve Deficit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Delayed Wound Healing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="130"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Hematoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="130"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Wound Problems: Dehiscence, Necrosis, Drainage, Superficial Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Humeral Fracture or Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Implant or Part Failure or Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Loosening or Migration of Implants or Parts</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="130"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Investigator must provide the Sponsor with at least 30 days to review publications for legal and regulatory compliance and will include in publications a statement that the study was supported by the Sponsor. Sponsor confidential information will not be submitted for publication without Sponsor consent. Sponsor may request delay of publication for 60 days to allow for patent application filing.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Clinical Operations</name_or_title>
      <organization>Zimmer Biomet, Inc.</organization>
      <phone>800-613-6131</phone>
      <email>clinicaldirector@zimmerbiomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

